Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines

被引:21
作者
Abbasi, Saed [1 ]
Uchida, Satoshi [1 ,2 ]
机构
[1] Kawasaki Inst Ind Promot, Innovat Ctr NanoMed, Kawasaki Ku, 3-25-14 Tonomachi, Kawasaki, Kanagawa 2100821, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Med Chem, Sakyo Ku, 1-5 Shimogamohangi Cho, Kyoto 6060823, Japan
基金
日本学术振兴会;
关键词
pDNA; mRNA; subunit vaccine; adjuvant; nonviral vaccine; DOUBLE-STRANDED-RNA; MONOPHOSPHORYL-LIPID-A; MODIFIED MESSENGER-RNA; T-CELL RESPONSES; INNATE IMMUNE-RESPONSE; PLASMID DNA; IN-VIVO; DRUG-DELIVERY; ANTIGEN PRESENTATION; DEXTRAN SULFATE;
D O I
10.3390/pharmaceutics13050644
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Subunit vaccines based on antigen-encoding nucleic acids have shown great promise for antigen-specific immunization against cancer and infectious diseases. Vaccines require immunostimulatory adjuvants to activate the innate immune system and trigger specific adaptive immune responses. However, the incorporation of immunoadjuvants into nonviral nucleic acid delivery systems often results in fairly complex structures that are difficult to mass-produce and characterize. In recent years, minimalist approaches have emerged to reduce the number of components used in vaccines. In these approaches, delivery materials, such as lipids and polymers, and/or pDNA/mRNA are designed to simultaneously possess several functionalities of immunostimulatory adjuvants. Such multifunctional immunoadjuvants encode antigens, encapsulate nucleic acids, and control their pharmacokinetic or cellular fate. Herein, we review a diverse class of multifunctional immunoadjuvants in nucleic acid subunit vaccines and provide a detailed description of their mechanisms of adjuvanticity and induction of specific immune responses.
引用
收藏
页数:29
相关论文
共 241 条
[21]   The impact of intragenic CpG content on gene expression [J].
Bauer, Asli Petra ;
Leikam, Doris ;
Krinner, Simone ;
Notka, Frank ;
Ludwig, Christine ;
Laengst, Gernot ;
Wagner, Ralf .
NUCLEIC ACIDS RESEARCH, 2010, 38 (12) :3891-3908
[22]   Chitosan-based drug delivery systems [J].
Bernkop-Schnuerch, Andreas ;
Duennhaupt, Sarah .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (03) :463-469
[23]   Innate immune sensing and its roots: the story of endotoxin [J].
Beutler, B ;
Rietschel, ET .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (02) :169-176
[24]   Assessment of Antigen-Specific and Cross-Reactive Antibody Responses to an MF59-Adjuvanted A/H5N1 Prepandemic Influenza Vaccine in Adult and Elderly Subjects [J].
Bihari, Ivan ;
Panczel, Gyula ;
Kovacs, Jozsef ;
Beygo, Jenny ;
Fragapane, Elena .
CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (12) :1943-1948
[25]   Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA [J].
Blakney, Anna K. ;
McKay, Paul F. ;
Bouton, Clement R. ;
Hu, Kai ;
Samnuan, Karnyart ;
Shattock, Robin J. .
MOLECULAR THERAPY, 2021, 29 (03) :1174-1185
[26]   Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA [J].
Blakney, Anna K. ;
McKay, Paul F. ;
Yus, Barbara Ibarzo ;
Aldon, Yoann ;
Shattock, Robin J. .
GENE THERAPY, 2019, 26 (09) :363-372
[27]   Self-amplifying RNA vaccines for infectious diseases [J].
Bloom, Kristie ;
van den Berg, Fiona ;
Arbuthnot, Patrick .
GENE THERAPY, 2021, 28 (3-4) :117-129
[28]  
Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]
[29]   The Toll-like receptor 3:dsRNA signaling complex [J].
Botos, Istvan ;
Liu, Lin ;
Wang, Yan ;
Segal, David M. ;
Davies, David R. .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2009, 1789 (9-10) :667-674
[30]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301